Dorsey Wright & Associates Celldex Therapeutics, Inc. Transaction History
Dorsey Wright & Associates
- $378 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding CLDX
# of Institutions
207Shares Held
61.2MCall Options Held
291KPut Options Held
246K-
Wellington Management Group LLP Boston, MA7.65MShares$271 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.51MShares$160 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$130 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.12MShares$111 Million2.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$110 Million0.02% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.66B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...